Human Longevity Inc. (HLI), a longevity-focused technology company, announced today the completion of an oversubscribed $39.8M Series B round led by TVM Capital Healthcare with participation from new and existing investors, including Panacea Venture and Emerging Technology Partners. This funding round will invest in HLI’s artificial intelligence health risk and recommendation platform, new longevity-focused technologies and services, and new expansion sites globally.
Launched in 2013 with a group of pioneers in precision medicine, HLI has made significant R&D progress in longevity. In 2020, the company published groundbreaking research in the Proceedings of the National Academy of Sciences, demonstrating the integration of whole-genome sequencing, comprehensive metabolomics, and advanced imaging to identify significant health risks.
Due to the company’s research results, they have created a 100+ Longevity care membership program to identify the early stages of major age-related health diseases, increase health span, and extend lifespan through the company’s clinical care team and data platform.
The 100+ Longevity Care program utilizes precision medicine health data, clinical care, and targeted interventions and also focuses on reducing biological age. Key components include whole genome sequencing, whole-body and brain MRI, comprehensive cardiac evaluation, body composition analysis, advanced blood biomarkers, and wearables. Accurate/proven personalized health data will be the major driver for science-backed precision medicine.
Early detection of health risks is a major component of proactive healthcare. It will save millions of lives while also significantly reducing healthcare costs in the future. By identifying potential issues at their inception, individuals could take timely steps to prevent or manage serious conditions.
HLI’s clinical care team successfully diagnosed early-stage conditions like cancer, cardiovascular disease, neurodegenerative disorders, and metabolic diseases. It also created personalized programs for members to optimize health and mitigate chronic disease risks.
